ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 150 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 24.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,050,000 | -43.6% | 55,652 | -64.8% | 0.00% | -50.0% |
Q2 2019 | $1,862,000 | +214.0% | 158,268 | +264.5% | 0.00% | +100.0% |
Q1 2019 | $593,000 | +11.7% | 43,417 | -16.2% | 0.00% | 0.0% |
Q4 2018 | $531,000 | -90.1% | 51,807 | -84.0% | 0.00% | -80.0% |
Q3 2018 | $5,377,000 | +144.6% | 322,970 | +132.2% | 0.01% | +150.0% |
Q2 2018 | $2,198,000 | -17.7% | 139,115 | -33.9% | 0.00% | 0.0% |
Q1 2018 | $2,672,000 | +315.6% | 210,377 | +274.3% | 0.00% | +100.0% |
Q4 2017 | $643,000 | -41.4% | 56,208 | -37.2% | 0.00% | 0.0% |
Q3 2017 | $1,097,000 | -27.7% | 89,511 | -32.5% | 0.00% | 0.0% |
Q2 2017 | $1,518,000 | -70.1% | 132,524 | -45.6% | 0.00% | -80.0% |
Q1 2017 | $5,071,000 | +19.8% | 243,807 | +19.8% | 0.01% | +25.0% |
Q4 2016 | $4,234,000 | -36.3% | 203,547 | +0.3% | 0.00% | -33.3% |
Q3 2016 | $6,648,000 | +42.4% | 202,839 | +8.5% | 0.01% | +20.0% |
Q2 2016 | $4,667,000 | +2.1% | 186,912 | +0.1% | 0.01% | -16.7% |
Q1 2016 | $4,571,000 | +21.3% | 186,633 | +63.7% | 0.01% | +50.0% |
Q4 2015 | $3,767,000 | +22.7% | 113,997 | +21.7% | 0.00% | 0.0% |
Q3 2015 | $3,069,000 | +1.2% | 93,665 | +63.6% | 0.00% | +33.3% |
Q2 2015 | $3,032,000 | +188.2% | 57,254 | +57.0% | 0.00% | +200.0% |
Q1 2015 | $1,052,000 | +139.6% | 36,460 | +142.0% | 0.00% | – |
Q4 2014 | $439,000 | +99.5% | 15,064 | -13.2% | 0.00% | – |
Q3 2014 | $220,000 | – | 17,364 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |